Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pinson

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Revue Neurologique|June 22, 2019
Charcot-Marie-Tooth (CMT)-like polyneuropathy revealing neurofibromatosis type 2: A case report and review of the literatureA Pegat, F Ducray, S Jeannin-Mayer, et al.
Annales De Dermatologie Et De Venereologie|November 6, 2007
[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]B Bensaid, F Giammarile, T Mognetti, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 20, 2000
[Cardiogenetics in the year 2000]S Pinson, C Guichard, D Lenoir, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 30, 2009
[Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1]G Blanchard, S Pinson, C Rousselle, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2014
[Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression]A Drouet, F Le Moigne, D Salamé, et al.
Clinical Endocrinology|March 12, 2008
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?C Cardot-Bauters, E Leteurtre, L Leclerc, et al.
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Journal Francais D'Ophtalmologie|May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]S Pinson, A Créange, S Barbarot, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Revue Neurologique|June 22, 2019
Charcot-Marie-Tooth (CMT)-like polyneuropathy revealing neurofibromatosis type 2: A case report and review of the literatureA Pegat, F Ducray, S Jeannin-Mayer, et al.
Annales De Dermatologie Et De Venereologie|November 6, 2007
[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1]B Bensaid, F Giammarile, T Mognetti, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 20, 2000
[Cardiogenetics in the year 2000]S Pinson, C Guichard, D Lenoir, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 30, 2009
[Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1]G Blanchard, S Pinson, C Rousselle, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 3, 2014
[Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression]A Drouet, F Le Moigne, D Salamé, et al.
Clinical Endocrinology|March 12, 2008
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?C Cardot-Bauters, E Leteurtre, L Leclerc, et al.
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Journal Francais D'Ophtalmologie|May 16, 2002
[Recommendations for the treatment of neurofibromatosis type 1]S Pinson, A Créange, S Barbarot, et al.
Pageof 2